Jasamai Malina, Balzarini Jan, Simons Claire
Medicinal Chemistry, Welsh School of Pharmacy, Cardiff University, Cardiff, CF10 3XF, UK.
J Enzyme Inhib Med Chem. 2008 Feb;23(1):56-61. doi: 10.1080/14756360701442340.
The synthesis of dideoxy-6-azathymidine 4'-thionucleoside 1-(2,3-dideoxy-4-thio-beta-D-erythro-pentofuranosyl)-(6-azathymidine) (2), and the L-nucleoside, 1-(4-thio-beta-L-erythro-pentofuranosyl)-(6-azathymidine) (3) and their evaluation against a wide panel of antiviral assays are described. The L-thionucleoside (3) was devoid of antiviral activity. The dideoxy-thionucleoside (2) was moderately active against vaccinia virus (VV) and the herpes simplex virus strains HSV-1 (strain KOS) and HSV-2 (strain G) (MIC 12 microM) and retained inhibitory activity vs a thymidine kinase-deficient strain HSV-1/TK(-), suggesting that (2) is not dependent on viral TK-catalysed phosphorylation for antiviral activity and/or may use an alternative metabolic activation pathway.
描述了双脱氧-6-氮杂胸苷4'-硫代核苷1-(2,3-二脱氧-4-硫代-β-D-赤式-戊呋喃糖基)-(6-氮杂胸苷)(2)和L-核苷1-(4-硫代-β-L-赤式-戊呋喃糖基)-(6-氮杂胸苷)(3)的合成及其针对多种抗病毒检测方法的评估。L-硫代核苷(3)没有抗病毒活性。双脱氧硫代核苷(2)对痘苗病毒(VV)以及单纯疱疹病毒株HSV-1(毒株KOS)和HSV-2(毒株G)具有中等活性(MIC为12微摩尔),并且对胸苷激酶缺陷型毒株HSV-1/TK(-)仍具有抑制活性,这表明(2)的抗病毒活性不依赖于病毒TK催化的磷酸化和/或可能使用替代的代谢活化途径。